ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
2020 · Molecular Cancer · 296 citations
https://doi.org/10.1186/s12943-020-01239-w
R
Rongliang Tong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.7K
Citations
21
h-index
27
i10-index
Rongliang Tong is an academic researcher from Hangzhou First People's Hospital. The author has contributed to research in topics: RNA modifications and cancer & MicroRNA in disease regulation & Cancer-related molecular mechanisms research. The author has an h-index of 21, co-authored 37 publications.
ORCID: 0000-0002-4364-7950Papers by this author
worksHigh-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
2020 · Oncogene · 192 citations
https://doi.org/10.1038/s41388-020-01450-5
Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5
2019 · EBioMedicine · 32 citations
https://doi.org/10.1016/j.ebiom.2019.05.029
ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation
2023 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-023-04191-7
Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database
2021 · BMC Gastroenterology · 15 citations
https://doi.org/10.1186/s12876-021-01786-6
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming
2025 · Translational Oncology · 4 citations
https://doi.org/10.1016/j.tranon.2025.102327
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat